Swiss Biotech Day: Zurich based LimmaTech Biologics is developing vaccines against antimicrobial resistant pathogens
May 5, 2025
07:35
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
CEO Franz-Werner Haas describes the rationale for developing vaccines for the antimicrobial space, he explains the company's E. coli based platform, and he walks us through the pipeline.
BiotechTV - News